All products are research-grade, lyophilized, and accompanied by a Certificate of Analysis. For licensed research professionals, 21+.

Next-generation GLP receptor research compound. Multi-variant dosing.

Eight-compound proprietary research blend. Single reconstitution protocol.

Seven-compound research blend formulated for parallel pathway studies.

Co-formulated BPC-157 and TB-500 for combined research protocols.

Synthetic GHRH analog. Lyophilized, single-vial format.

Tripeptide-copper complex. Variable dosing for extended studies.

Sterile bacteriostatic water. 0.9% benzyl alcohol preservative.